Gryphon Financial Partners’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$215K Buy
+2,746
New +$215K 0.03% 293
2025
Q1
Sell
-2,946
Closed -$218K 279
2024
Q4
$218K Sell
2,946
-1,374
-32% -$102K 0.03% 237
2024
Q3
$285K Sell
4,320
-365
-8% -$24.1K 0.04% 239
2024
Q2
$433K Sell
4,685
-457
-9% -$42.2K 0.06% 180
2024
Q1
$491K Sell
5,142
-1,312
-20% -$125K 0.08% 156
2023
Q4
$681K Buy
6,454
+1,698
+36% +$179K 0.12% 118
2023
Q3
$329K Buy
4,756
+3,432
+259% +$238K 0.08% 134
2023
Q2
$125K Sell
1,324
-3,616
-73% -$341K 0.03% 195
2023
Q1
$409K Buy
4,940
+5
+0.1% +$414 0.09% 120
2022
Q4
$368K Buy
4,935
+157
+3% +$11.7K 0.09% 130
2022
Q3
$395K Sell
4,778
-165
-3% -$13.6K 0.1% 114
2022
Q2
$470K Buy
4,943
+365
+8% +$34.7K 0.11% 101
2022
Q1
$538K Sell
4,578
-698
-13% -$82K 0.11% 104
2021
Q4
$684K Sell
5,276
-409
-7% -$53K 0.13% 93
2021
Q3
$643K Sell
5,685
-571
-9% -$64.6K 0.14% 84
2021
Q2
$520K Buy
6,256
+126
+2% +$10.5K 0.12% 86
2021
Q1
$512K Sell
6,130
-18
-0.3% -$1.5K 0.12% 92
2020
Q4
$561K Sell
6,148
-11
-0.2% -$1K 0.14% 78
2020
Q3
$492K Sell
6,159
-24
-0.4% -$1.92K 0.15% 77
2020
Q2
$428K Sell
6,183
-1,623
-21% -$112K 0.13% 82
2020
Q1
$491K Sell
7,806
-585
-7% -$36.8K 0.18% 61
2019
Q4
$653K Buy
8,391
+48
+0.6% +$3.74K 0.17% 66
2019
Q3
$611K Sell
8,343
-162
-2% -$11.9K 0.18% 64
2019
Q2
$524K Sell
8,505
-108
-1% -$6.65K 0.15% 76
2019
Q1
$550K Hold
8,613
0.16% 70
2018
Q4
$440K Sell
8,613
-162
-2% -$8.28K 0.11% 127
2018
Q3
$509K Buy
8,775
+8,088
+1,177% +$469K 0.15% 78
2018
Q2
$34K Hold
687
0.02% 290
2018
Q1
$32K Sell
687
-42
-6% -$1.96K 0.02% 299
2017
Q4
$27K Buy
+729
New +$27K 0.02% 350